• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Nonprescription Products of Internet Retailers for the Prevention and Management of Herpes Zoster and Postherpetic Neuralgia: Analysis of Consumer Reviews on Amazon.互联网零售商销售的非处方产品用于预防和治疗带状疱疹和疱疹后神经痛:对亚马逊消费者评论的分析。
JMIR Dermatol. 2021 Feb 8;4(1):e24971. doi: 10.2196/24971.
2
Risk of herpes zoster and postherpetic neuralgia in patients with psoriasis treated with biologics: a nationwide study using a target trial emulation framework.使用生物制剂治疗的银屑病患者发生带状疱疹和带状疱疹后神经痛的风险:一项采用目标试验模拟框架的全国性研究。
Br J Dermatol. 2025 Jun 20;193(1):105-114. doi: 10.1093/bjd/ljaf101.
3
Corticosteroids for preventing postherpetic neuralgia.皮质类固醇类药物预防带状疱疹后神经痛。
Cochrane Database Syst Rev. 2023 Dec 5;12(12):CD005582. doi: 10.1002/14651858.CD005582.pub5.
4
Corticosteroids for preventing postherpetic neuralgia.用于预防带状疱疹后神经痛的皮质类固醇
Cochrane Database Syst Rev. 2013 Mar 28(3):CD005582. doi: 10.1002/14651858.CD005582.pub4.
5
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.社区居住的老年人跌倒预防干预措施:系统评价和荟萃分析的益处、危害以及患者的价值观和偏好。
Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3.
6
Vaccines for preventing herpes zoster in older adults.用于预防老年人带状疱疹的疫苗。
Cochrane Database Syst Rev. 2023 Oct 2;10(10):CD008858. doi: 10.1002/14651858.CD008858.pub5.
7
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
8
Oxycodone for neuropathic pain and fibromyalgia in adults.羟考酮用于成人神经性疼痛和纤维肌痛。
Cochrane Database Syst Rev. 2014 Jun 23(6):CD010692. doi: 10.1002/14651858.CD010692.pub2.
9
Gabapentin for chronic neuropathic pain and fibromyalgia in adults.加巴喷丁用于成人慢性神经性疼痛和纤维肌痛。
Cochrane Database Syst Rev. 2014 Apr 27;2014(4):CD007938. doi: 10.1002/14651858.CD007938.pub3.
10
Interventions to improve safe and effective medicines use by consumers: an overview of systematic reviews.改善消费者安全有效用药的干预措施:系统评价概述
Cochrane Database Syst Rev. 2014 Apr 29;2014(4):CD007768. doi: 10.1002/14651858.CD007768.pub3.

引用本文的文献

1
Consumer Perceptions of Home-Based Percussive Massage Therapy for Musculoskeletal Concerns: Inductive Thematic Qualitative Analysis.消费者对基于家庭的肌肉骨骼问题敲击按摩疗法的认知:归纳主题定性分析
JMIR Rehabil Assist Technol. 2024 Feb 5;11:e52328. doi: 10.2196/52328.

本文引用的文献

1
Herpes Zoster and Postherpetic Neuralgia: Changing Incidence Rates From 1994 to 2018 in the United States.带状疱疹和带状疱疹后神经痛:1994 年至 2018 年美国发病率的变化。
Clin Infect Dis. 2021 Nov 2;73(9):e3210-e3217. doi: 10.1093/cid/ciaa1185.
2
Postherpetic neuralgia and recalcitrant cystic lesions following herpes zoster: A case report and review of treatment options.带状疱疹后神经痛及带状疱疹后顽固性囊性损害:1例报告及治疗选择综述
Dermatol Ther. 2020 Jul;33(4):e13793. doi: 10.1111/dth.13793. Epub 2020 Jul 12.
3
Consumer Perceptions of Wearable Technology Devices: Retrospective Review and Analysis.消费者对可穿戴技术设备的认知:回顾性评价与分析。
JMIR Mhealth Uhealth. 2020 Apr 20;8(4):e17544. doi: 10.2196/17544.
4
Postherpetic Neuralgia: Current Evidence on the Topical Film-Forming Spray with Bupivacaine Hydrochloride and a Review of Available Treatment Strategies.带状疱疹后神经痛:盐酸布比卡因贴膜剂的最新证据及现有治疗策略综述。
Adv Ther. 2020 May;37(5):2003-2016. doi: 10.1007/s12325-020-01335-9. Epub 2020 Apr 15.
5
Hypovitaminosis Din Postherpetic Neuralgia-High Prevalence and Inverse Association with Pain: A Retrospective Study.疱疹后神经痛中的维生素 D 缺乏症——高患病率和与疼痛的负相关:一项回顾性研究。
Nutrients. 2019 Nov 15;11(11):2787. doi: 10.3390/nu11112787.
6
Treatment Patterns and Medication Use in Patients with Postherpetic Neuralgia.带状疱疹后神经痛患者的治疗模式和药物使用情况。
J Manag Care Spec Pharm. 2019 Dec;25(12):1387-1396. doi: 10.18553/jmcp.2019.19093. Epub 2019 Oct 7.
7
Interventional Treatments for Postherpetic Neuralgia: A Systematic Review.疱疹后神经痛的介入治疗:系统评价。
Pain Physician. 2019 May;22(3):209-228.
8
Herbal medicinal products or preparations for neuropathic pain.用于神经性疼痛的草药产品或制剂。
Cochrane Database Syst Rev. 2019 Apr 2;4(4):CD010528. doi: 10.1002/14651858.CD010528.pub4.
9
Modalities in managing postherpetic neuralgia.带状疱疹后神经痛的治疗方法
Korean J Pain. 2018 Oct;31(4):235-243. doi: 10.3344/kjp.2018.31.4.235. Epub 2018 Oct 1.
10
Treatment of Postherpetic Neuralgia With Intravenous Administration of Zinc Sulfate: A Case Report.静脉注射硫酸锌治疗带状疱疹后神经痛:一例报告
A A Pract. 2018 Jul 1;11(1):8-10. doi: 10.1213/XAA.0000000000000712.

互联网零售商销售的非处方产品用于预防和治疗带状疱疹和疱疹后神经痛:对亚马逊消费者评论的分析。

Nonprescription Products of Internet Retailers for the Prevention and Management of Herpes Zoster and Postherpetic Neuralgia: Analysis of Consumer Reviews on Amazon.

机构信息

Olive View-University of California Los Angeles Medical Center, Sylmar, CA, United States.

College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA, United States.

出版信息

JMIR Dermatol. 2021 Feb 8;4(1):e24971. doi: 10.2196/24971.

DOI:10.2196/24971
PMID:37632802
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10501527/
Abstract

BACKGROUND

Herpes zoster affects approximately 1 million people annually in the United States, with postherpetic neuralgia as the most common complication. The frequent prescription of opioids as the first-line medication for herpes zoster or postherpetic neuralgia contributes to the increasing health care costs of their treatment. Despite the advent of internet retailers providing alternative products for the prevention and management these conditions, there are limited studies on the availability, ingredients, and consumer preference for the products.

OBJECTIVE

This study used the internet retailer Amazon to determine the availability of products for the management of herpes zoster and postherpetic neuralgia, and assessed consumer preference based on listed ingredients.

METHODS

The internet retailer Amazon was used to perform a search for products related to "shingles" in September 2020. Top products sorted by reviews and ratings were determined to be either shingles-specific (including "shingles" in either the product title or description) or shingles-nonspecific. Analysis of price, rating, type of vehicle, and ingredients was performed. The types of vehicles, ingredients, and percentages of positive and negative reviews related to "shingles" of the product groups were analyzed with a two-tailed two-sample proportions Z-test to assess the difference between shingles-specific and shingles-nonspecific products. Statistical significance was judged at P<.05.

RESULTS

The top 131 products among over 3000 products retrieved were determined based on a rating of 4 or more stars after searching for the term "shingles" on Amazon. Forty-six of the 131 products (35.1%) were shingles-specific. Shingles-nonspecific products were more likely to have positive reviews mentioning "shingles" (P=.005). Vehicles, balms (P=.02), and salves (P=.04) were more likely to be shingles-specific, whereas tablets or capsules (P=.002) were more likely to be shingles-nonspecific. Among the ingredients analyzed, aloe vera was the top-ranked ingredient, included in 29 of the 131 total products (22.1%). Aloe vera (P=.01), lemon balm (P<.001), vitamin E (P=.03), and peppermint oil (P=.008) were more likely to be included in the shingles-specific products, whereas magnesium (P=.01) was more likely to be included in shingles-nonspecific products.

CONCLUSIONS

There is an abundance of products and ingredients being used for the management and treatment of shingles with certain ingredients preferred by consumers. There is a discrepancy between approved ingredients and the ingredients preferred by consumers. Furthermore, there are insufficient studies on ingredients used by consumers on internet retailers such as Amazon, and future studies can focus on the effectiveness of popular ingredients to decrease misinformation on the internet.

摘要

背景

在美国,每年约有 100 万人感染带状疱疹,其最常见的并发症是带状疱疹后神经痛。由于经常将阿片类药物作为带状疱疹或带状疱疹后神经痛的一线药物处方,这导致了其治疗的医疗保健费用不断增加。尽管互联网零售商提供了用于预防和管理这些疾病的替代产品,但关于这些产品的供应、成分和消费者偏好的研究有限。

目的

本研究使用互联网零售商亚马逊(Amazon)来确定用于管理带状疱疹和带状疱疹后神经痛的产品的供应情况,并根据列出的成分评估消费者偏好。

方法

2020 年 9 月,使用互联网零售商亚马逊(Amazon)对与“带状疱疹”相关的产品进行了搜索。根据评论和评分对排名最高的产品进行了确定,这些产品要么是带状疱疹专用(产品标题或描述中包含“带状疱疹”),要么是带状疱疹非专用。对价格、评分、剂型和成分进行了分析。使用双侧两样本比例 Z 检验分析了产品组中与“带状疱疹”相关的剂型、成分以及正面和负面评论的百分比,以评估带状疱疹专用产品和带状疱疹非专用产品之间的差异。以 P<.05 为具有统计学意义。

结果

在亚马逊上搜索“带状疱疹”后,根据评分 4 星或更高,从 3000 多种产品中确定了前 131 种产品。在这 131 种产品中,有 46 种(35.1%)是带状疱疹专用产品。带状疱疹非专用产品更有可能获得提及“带状疱疹”的正面评价(P=.005)。软膏(P=.02)和乳膏(P=.04)更有可能是带状疱疹专用产品,而片剂或胶囊(P=.002)更有可能是带状疱疹非专用产品。在所分析的成分中,库拉索芦荟是排名最高的成分,在 131 种总产品中包含 29 种(22.1%)。库拉索芦荟(P=.01)、柠檬香脂(P<.001)、维生素 E(P=.03)和薄荷油(P=.008)更有可能包含在带状疱疹专用产品中,而镁(P=.01)更有可能包含在带状疱疹非专用产品中。

结论

有大量的产品和成分被用于管理和治疗带状疱疹,某些成分受到消费者的青睐。批准的成分与消费者偏好的成分之间存在差异。此外,关于消费者在亚马逊等互联网零售商上使用的成分的研究不足,未来的研究可以集中研究流行成分的有效性,以减少互联网上的错误信息。